Statins use and risk of depression: A systematic review and meta-analysis

被引:71
|
作者
Parsaik, Ajay K. [1 ,2 ]
Singh, Balwinder [2 ]
Murad, M. Hassan [3 ,4 ]
Singh, Kuljit [5 ]
Mascarenhas, Soniya S. [6 ]
Williams, Mark D. [7 ]
Lapid, Maria I. [7 ]
Richardson, Jarrett W. [7 ]
West, Colin P. [8 ,9 ]
Rummans, Teresa A. [7 ,10 ]
机构
[1] Univ Texas Med Sch Houston, Dept Psychiat & Behav Sci, Houston, TX USA
[2] Mayo Clin, Mayo Alzheimers Dis Res Ctr, Rochester, MN USA
[3] Mayo Clin, Rochester, MN USA
[4] Mayo Clin, Div Prevent Med, Rochester, MN USA
[5] Queen Elizabeth Hosp, Dept Cardiol, Woodville South, SA, Australia
[6] London Training Coll, London, England
[7] Mayo Clin, Dept Psychiat, Rochester, MN 55905 USA
[8] Mayo Clin, Div Gen Internal Med, Rochester, MN USA
[9] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA
[10] Mayo Clin, Dept Psychiat, Jacksonville, FL 32224 USA
基金
美国国家卫生研究院;
关键词
Stains; Depression; Systematic review; Meta-analysis; COA REDUCTASE INHIBITORS; AVERAGE CHOLESTEROL LEVELS; PLACEBO-CONTROLLED TRIAL; CORONARY-HEART-DISEASE; SERUM-CHOLESTEROL; MYOCARDIAL-INFARCTION; PRIMARY PREVENTION; LOWERING DRUGS; SIMVASTATIN; PRAVASTATIN;
D O I
10.1016/j.jad.2013.11.026
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Importance: Statin use has been associated with depression; however studies of the association between statin use and depression have yielded mixed results. Objective: To determine whether statin use is associated with depression and to evaluate the evidence supporting this association. Data sources: Ovid MEDLINE In Process & Other Non Indexed Citations, Ovid MEDLINE, EMBASE, PsycInfo, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, and Scopus were searched through December 28, 2012. Study selection: We included studies that evaluated exposure to statins, reported the development of depression, and relative risks or odds ratios (ORs) or provided data for their estimation. Two reviewers screened 981 abstracts independently using a standardized form, reviewed full text. of 59 selected articles, and included 7 studies in this metaanalysis. Data extraction and synthesis: Study design, statin exposure, development of depression, and study quality were extracted by 2 independent reviewers. A pooled OR with 95% confidence interval (CI) was estimated using the random effects model and heterogeneity was assessed using Cochran's Q Lest and the 12 statistic. Results: Seven observational studies (4 cohort, 2 nested case-control, and 1 cross-sectional) from 5 countries enrolling 9187 patients were included. Statin users were 32% less likely to develop depression than nonusers (adjusted OR, 0.68; 95% CI, 0.52-0.89). Modest heterogeneity was observed between the studies (I-2=55%, P=0.01), which could be accounted for by one study, exclusion of which removed the heterogeneity (P=0.40, I-2=2%) and further strengthened the antidepressant effect of statin (adjusted OR, 0.63; 95% CI, 0.43-0.93). Heterogeneity could not be explained by study design or study population. The quality of supporting evidence was fair. Conclusions and relevance: This systematic review and meta-analysis suggests that stain use is associated with lower risk for depression. However, higher-quality studies are needed to confirm the magnitude of this association. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:62 / 67
页数:6
相关论文
共 50 条
  • [21] Systematic review with network meta-analysis: statins and risk of hepatocellular carcinoma
    Zhou, Yao-Yao
    Zhu, Gui-Qi
    Wang, Yue
    Zheng, Ji-Na
    Ruan, Lu-Yi
    Cheng, Zhang
    Hu, Bin
    Fu, Shen-Wen
    Zheng, Ming-Hua
    ONCOTARGET, 2016, 7 (16) : 21753 - 21762
  • [22] Statins and risk of cataracts: A systematic review and meta-analysis of observational studies
    Alves, Carlos
    Mendes, Diogo
    Marques, Francisco Batel
    CARDIOVASCULAR THERAPEUTICS, 2018, 36 (06)
  • [23] Statins and risk of amyotrophic lateral sclerosis: a systematic review and meta-analysis
    Fardin Nabizadeh
    Mohammad Balabandian
    Amir Mohammad Sharafi
    Ali Ghaderi
    Mohammad Reza Rostami
    Abdorreza Naser Moghadasi
    Acta Neurologica Belgica, 2022, 122 : 979 - 986
  • [24] Statins and cancer: A systematic review and meta-analysis
    Kuoppala, Jaana
    Lamminpaa, Anne
    Pukkala, Eero
    EUROPEAN JOURNAL OF CANCER, 2008, 44 (15) : 2122 - 2132
  • [25] Substance use during pregnancy and risk of postpartum depression: a systematic review and meta-analysis
    Pacho, Malein
    Aymerich, Claudia
    Pedruzo, Borja
    de Pablo, Gonzalo Salazar
    Sesma, Eva
    Bordenave, Marta
    Dieguez, Rodrigo
    Lopez-Zorroza, Itziar
    Herrero, Jon
    Laborda, Maria
    Fernandez-Rivas, Aranzazu
    Garcia-Rizo, Clemente
    Gonzalez-Torres, Miguel Angel
    Catalan, Ana
    FRONTIERS IN PSYCHIATRY, 2023, 14
  • [26] The risk of depression in the menopausal stages: A systematic review and meta-analysis
    Badawy, Yasmeen
    Spector, Aimee
    Li, Zishi
    Desai, Roopal
    JOURNAL OF AFFECTIVE DISORDERS, 2024, 357 : 126 - 133
  • [27] Statins Use and Risk of Breast Cancer Recurrence and Death: A Systematic Review and Meta-Analysis of Observational Studies
    Mansourian, Marjan
    Haghjooy-Javanmard, Shaghayegh
    Eshraghi, Azadeh
    Vaseghi, Golnaz
    Hayatshahi, Alireza
    Thomas, Jean
    JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2016, 19 (01): : 72 - 81
  • [28] Use of statins and the risk of delirium in critically ill and surgical patients Protocol of a systematic review and meta-analysis
    Zeng, Hai
    Li, Zunjiang
    He, Guoxin
    Han, Yanhong
    Fu, Wenbin
    Wen, Junru
    MEDICINE, 2018, 97 (51)
  • [29] Statins use and the risk of colorectal cancer in patients with inflammatory bowel disease: A Systematic review and meta-analysis
    Jung, B. W.
    Lee, W. M.
    Choi, S.
    Lee, H. S.
    Park, J. J.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1256 - I1256
  • [30] Statins and associated risk of pneumonia: a systematic review and meta-analysis of observational studies
    Chun Shing Kwok
    Jessica Ka-Yan Yeong
    Richard M. Turner
    Rodrigo Cavallazzi
    Sonal Singh
    Yoon Kong Loke
    European Journal of Clinical Pharmacology, 2012, 68 : 747 - 755